Diabetic cardiomyopathy


<p style="&quot;text-align:" justify;"=""> 

Diabetes Mellitus(DM) appears to contribute directly to the development of cardiomyopathy(CMP), rather than solely via coronary atherosclerosis and hypertension. This diabetic CMP has been described in many non-invasive studies and includes changes that occur in LV structure and cardiac function of diabetics. Specifically, diabetics tend to have greater cardiac mass, particularly LV mass, than those without DM. This may be related to an increased adipocyte release of cytokines such as leptin and resistin which have hypertrophic effects on cardiomyocytes. One study looking at a multi-ethnic population found that the likelihood of having LV mass that exceeds the 75th percentile is greater in patients with T2DM, even after adjusting for covariates. Patients with DM also tend to have a slightly diminished diastolic function compared to nondiabetics. One possible mechanism could be that increased triglyceride synthesis in patients with DM leads to increased myocardial triglyceride content. Increased cardiac triglyceride accumulation is associated with lipotoxicity and altered calcium haemostasis in the myocardium, both of which negatively impact diastolic function. This could facilitate justify the finding that 40%-75% of people with DM and no signs of unconcealed arterial blood vessel malady (CAD) suffer from pulsation dysfunction.

    Related Conference of Diabetic cardiomyopathy

    May 30-31, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Istanbul, Turkey
    July 29-30, 2019

    21st Asia Pacific Diabetes Conference

    Sydney, Australia
    June 27-28, 2019

    18th Global Conference on Diabetes & Nursing Care

    Amsterdam, Netherlands
    July 17-18, 2019

    28th European Diabetes Congress

    | Edinburgh, Scotland
    September 16-17, 2019

    International Conference on Diabetes and Heart diseases

    Athens, Greece
    September 20-21, 2019

    15th World Congress on Endocrinology & Diabetes

    | Prague, Czech Republic
    September 20-21, 2019 |

    Euro Diabetes Congress & Expo

    Prague, Czech Republic
    October 14-15, 2019

    Global congress on Endocrinology and Gynecology

    Sydney, Australia
    October 23-24, 2019

    World conference on Diabetes and Heart Congress

    October 23-24, 2019

    Annual Summit on Metabolomics

    Amsterdam, Netherlands
    October 25-26, 2019

    29th World Diabetes & Heart Congress

    | Radisson Narita | Tokyo, Japan
    November 25-26, 2019

    Global Summit On Diabetes & Endocrinology

    Yokohama, Japan
    November 29-30, 2019

    World conference on Diabetes and Endocrine Complications

    December 02-03, 2019

    14th European Diabetes and Endocrinology Congress

    | Barcelona, Spain
    December 04-05, 2019

    3rd Annual Congress on Diabetes and Its Complications

    Tokyo, Japan
    December 12-13, 2019

    Annual Congress on Diabetes and Endocrinology

    | Dubai, UAE

    Diabetic cardiomyopathy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in